Cargando…
Autoimmune Diabetes Is Suppressed by Treatment with Recombinant Human Tissue Kallikrein-1
The kallikrein-kinin system (KKS) comprises a cascade of proteolytic enzymes and biogenic peptides that regulate several physiological processes. Over-expression of tissue kallikrein-1 and modulation of the KKS shows beneficial effects on insulin sensitivity and other parameters relevant to type 2 d...
Autores principales: | Maneva-Radicheva, Lilia, Amatya, Christina, Parker, Camille, Ellefson, Jacob, Radichev, Ilian, Raghavan, Arvind, Charles, Matthew L., Williams, Mark S., Robbins, Mark S., Savinov, Alexei Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178025/ https://www.ncbi.nlm.nih.gov/pubmed/25259810 http://dx.doi.org/10.1371/journal.pone.0107213 |
Ejemplares similares
-
Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus
por: Kolodka, Tadeusz, et al.
Publicado: (2014) -
Nardilysin-Dependent Proteolysis of Cell-Associated VTCN1 (B7-H4) Marks Type 1 Diabetes Development
por: Radichev, Ilian A., et al.
Publicado: (2014) -
Pharmacological effects of recombinant human tissue kallikrein on bradykinin B(2) receptors
por: Charest-Morin, Xavier, et al.
Publicado: (2015) -
Transgenic Overexpression of Tissue‐Nonspecific Alkaline Phosphatase (TNAP) in Vascular Endothelium Results in Generalized Arterial Calcification
por: Savinov, Alexei Y., et al.
Publicado: (2015) -
New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
por: Cabello-Olmo, Miriam, et al.
Publicado: (2019)